No connection

Search Results

CVSA

NEUTRAL
$107.63 Live
Covista Inc. · NYSE
Target $153.75 (+42.9%)
$86.97 52W Range $156.26
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$3.71B
P/E
15.85
ROE
18.0%
Profit margin
13.4%
Debt/Equity
0.53
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
CVSA presents a dichotomy between strong operational performance and deteriorating technicals. While the Piotroski F-Score of 4/9 indicates stable but non-optimal financial health, the company boasts an exceptional earnings track record with consistent beats over 25 quarters. Valuation is attractive on a PEG basis (0.82), though the current price of $107.63 trades at a premium to both the Graham Number ($77.96) and Intrinsic Value ($95.4). The primary concerns are a bearish technical trend (-29.6% over 6 months) and weak liquidity ratios.

Key Strengths

Exceptional earnings track record with consistent beats over 25 quarters
Strong profitability metrics including 57.38% gross margin and 18.03% ROE
Attractive valuation relative to growth (PEG Ratio of 0.82)
Manageable leverage with a Debt/Equity ratio of 0.53
Significant analyst upside with a target price of $153.75

Key Risks

Poor short-term liquidity indicated by a Current Ratio of 0.68 and Quick Ratio of 0.49
Strong bearish technical momentum (0/100 trend score, -29.6% 6-month return)
Trading at a premium to the Graham Number and calculated Intrinsic Value
Lack of dividend yield provides no floor for long-term holders during volatility
Earnings growth (4.70% YoY) is lagging significantly behind revenue growth (12.40%)
AI Fair Value Estimate
Based on comprehensive analysis
$101.5
-5.7% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
56
Moderate
Value
70
Future
75
Past
90
Health
45
Dividend
0
AI Verdict
Fundamental strength masked by liquidity risks and technical decay.
Key drivers: Consistent EPS surprises, Low PEG ratio, Liquidity crunch (Current Ratio < 1), Bearish price action
Confidence
90%
Value
70/100

Ref P/E, PEG, Graham Number

Positives
  • P/E of 15.85 is well below sector average of 34.01
  • PEG ratio < 1.0 suggests undervaluation relative to growth
Watchpoints
  • Price is ~38% above Graham Number
  • Price is ~13% above Intrinsic Value
Future
75/100

Ref Growth rates

Positives
  • Strong recent Q/Q EPS growth of 38.9%
  • Consistent revenue growth of 12.4%
Watchpoints
  • YoY earnings growth is modest at 4.7%
Past
90/100

Ref Historical trends

Positives
  • Remarkable consistency in beating analyst estimates over 25 quarters
  • Strong 5-year price appreciation (+177.1%)
Watchpoints
  • Recent 6-month price collapse
Health
45/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Low Debt/Equity ratio (0.53)
Watchpoints
  • Piotroski F-Score of 4/9 is only mediocre
  • Current Ratio (0.68) and Quick Ratio (0.49) indicate liquidity stress
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend payments
  • 0/100 dividend strength score

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$107.63
Analyst Target
$153.75
Upside/Downside
+42.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CVSA and closest competitors.

Updated 2026-04-24
CVS
Covista Inc.
Primary
5Y
+177.1%
3Y
+165.2%
1Y
+3.0%
6M
-29.6%
1M
-7.2%
1W
-8.7%
CAL
Cal-Maine Foods, Inc.
Peer
5Y
+153.1%
3Y
+66.2%
1Y
-10.2%
6M
-14.8%
1M
-12.0%
1W
-2.4%
MZT
The Marzetti Company
Peer
5Y
-12.7%
3Y
-23.5%
1Y
-22.1%
6M
-12.8%
1M
-2.8%
1W
-1.7%
BRB
BellRing Brands, Inc.
Peer
5Y
+13.1%
3Y
+2.4%
1Y
-64.0%
6M
-49.5%
1M
-8.2%
1W
+15.7%
FRP
Freshpet, Inc.
Peer
5Y
-60.9%
3Y
+1.6%
1Y
-19.6%
6M
+33.2%
1M
-18.5%
1W
+12.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
15.85
Forward P/E
12.29
PEG Ratio
0.82
P/B Ratio
2.71
P/S Ratio
1.97
EV/Revenue
2.32
EV/EBITDA
10.23
Market Cap
$3.71B

Profitability

Profit margins and return metrics

Profit Margin 13.41%
Operating Margin 22.88%
Gross Margin 57.38%
ROE 18.03%
ROA 8.8%

Growth

Revenue and earnings growth rates

Revenue Growth +12.4%
Earnings Growth +4.7%
Q/Q Revenue Growth +12.43%
Q/Q Earnings Growth +0.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.53
Moderate
Current Ratio
0.68
Weak
Quick Ratio
0.49
Poor
Cash/Share
$1.63

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.5B
Gross Margin
59.2%
Op. Margin
22.9%
Net Margin
15.2%
Total Assets
$2.6B
Liabilities
$1.2B
Equity
$1.4B
Debt/Equity
0.90x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
51%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-01-28
$2.43
+11.1% surprise
2025-10-30
$1.75
+10.9% surprise
2025-08-07
$1.66
+8.3% surprise

Consumer Defensive Sector Comparison

Comparing CVSA against 155 companies in the Consumer Defensive sector (9 bullish, 56 neutral, 90 bearish)
P/E Ratio
15.85
This Stock
vs
36.74
Sector Avg
-56.9% (Discount)
Return on Equity (ROE)
18.03%
This Stock
vs
-13.62%
Sector Avg
-232.4% (Below Avg)
Profit Margin
13.41%
This Stock
vs
-8.54%
Sector Avg
-257.0% (Weaker)
Debt to Equity
0.53
This Stock
vs
1.98
Sector Avg
-73.3% (Less Debt)
Revenue Growth
12.4%
This Stock
vs
121.62%
Sector Avg
-89.8% (Slower)
Current Ratio
0.68
This Stock
vs
2.37
Sector Avg
-71.1% (Weaker)

Similar Companies

Peer comparison within the same industry

CVSA Covista Inc.
NEUTRAL
Mkt Cap
$3.7B
P/E
15.9
ROE
18.0%
Price
$107.63
CALM Cal-Maine Foods, Inc.
BULLISH
Mkt Cap
$3.7B
P/E
5.4
ROE
27.3%
Price
$77.24
 Compare with CVSA
MZTI The Marzetti Company
NEUTRAL
Mkt Cap
$3.9B
P/E
21.8
ROE
17.9%
Price
$142.31
 Compare with CVSA
BRBR BellRing Brands, Inc.
NEUTRAL
Mkt Cap
$3.3B
P/E
16.5
ROE
-%
Price
$27.66
 Compare with CVSA
FRPT Freshpet, Inc.
NEUTRAL
Mkt Cap
$3.3B
P/E
24.7
ROE
12.3%
Price
$66.63
 Compare with CVSA

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

MALAFRONTE MICHAEL W
Director
Buy
2026-03-11
36,036 shares · $3,635,414
MALAFRONTE MICHAEL W
Director
Buy
2026-03-03
1,200 shares · $117,564
BEARD STEPHEN W.
Chief Executive Officer
Gift
2025-12-10
5,332 shares
KISER GEORGETTE D.
Director
Stock Award
2025-11-12
1,445 shares · $139,963
COX KAREN SUE
Officer
Stock Award
2025-11-12
581 shares · $56,276
PHELAN, ROBERT JOHN
Chief Financial Officer
Stock Award
2025-11-12
4,259 shares · $412,527
GANGADHARAN MANJUNATH
Officer
Stock Award
2025-11-12
890 shares · $86,205
VANDENBOSCH BETTY M
Director
Stock Award
2025-11-12
1,445 shares · $139,963
HERRERA MAURICE
Officer
Stock Award
2025-11-12
1,750 shares · $169,505
BETZ MICHAEL
Officer
Stock Award
2025-11-12
5,575 shares · $539,994
KREHBIEL WILLIAM V
Director
Stock Award
2025-11-12
1,445 shares · $139,963
TRENT EVAN
Officer
Stock Award
2025-11-12
1,673 shares · $162,047
LILES SCOTT
Officer
Stock Award
2025-11-12
2,613 shares · $253,095
HILL SARA
Officer
Stock Award
2025-11-12
1,673 shares · $162,047
NOEL MEGAN
Officer
Stock Award
2025-11-12
2,226 shares · $215,610
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-09

CVSA announced its first-quarter financial results for 2026.

8-K
8-K
2026-03-03

CVSA likely filed this 8-K to announce its financial results for the fiscal year ended December 31, 2025.

8-K
8-K
2026-02-24

CVSA likely filed this 8-K to announce its fourth quarter and full-year financial results.

8-K
8-K
2026-02-06

CVSA filed an 8-K on February 6, 2026, likely to announce its financial results for the preceding period.

10-Q
10-Q
2026-01-28

CVSA filed its quarterly 10-Q report on January 28, 2026. The filing includes a section on risk factors under Item 1A, although specific financial highlights and detailed risk descriptions were not provided in the available excerpt.

8-K
8-K
2026-01-28

CVSA filed an 8-K on January 28, 2026, likely to announce its fourth quarter and full year financial results.

8-K
8-K
2025-12-15
8-K
8-K
2025-11-14

CVSA filed an 8-K on November 14, 2025, likely to announce its third-quarter financial results.

10-Q
10-Q
2025-10-30

CVSA filed its 10-Q on October 30, 2025. The filing includes a section on Risk Factors under Item 1A, although specific financial highlights and detailed risk descriptions were not provided in the available excerpt.

8-K
8-K
2025-10-30

CVSA filed an 8-K on October 30, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-10-07
DEF 14A
DEF 14A
2025-10-02
10-K
10-K
2025-08-07
8-K
8-K
2025-08-07
8-K
8-K
2025-07-21
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
4 analysts
Barrington Research
2026-04-17
Maintains
Outperform Outperform
Truist Securities
2026-03-24
init
Buy
Barrington Research
2026-03-02
Maintains
Outperform Outperform
Barrington Research
2026-01-29
Maintains
Outperform Outperform
Barrington Research
2025-10-31
Maintains
Outperform Outperform

Past News Coverage

Recent headlines mentioning CVSA from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile